Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy

Details for Australian Patent Application No. 2005316403 (hide)

Owner Genentech, Inc.

Inventors Agarwal, Sunil

Agent Griffith Hack

Pub. Number AU-A-2005316403

PCT Pub. Number WO2006/066086

Priority 60/637,169 17.12.04 US

Filing date 16 December 2005

Wipo publication date 22 June 2006

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/066086 Priority application(s): WO2006/066086

15 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005316405-Methods for treating autoimmune disorders

2005316397-3, 5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo [4,5-d]pyrimidin-2-one compounds and prodrugs thereof